Novel Methods of Monitoring the Synthesis of N-L-Leucyldoxorubicin: MEKC-LIF and HPLC-LIF-MS
2010-04-21
Loading...
View/Download File
Persistent link to this item
Statistics
View StatisticsJournal Title
Journal ISSN
Volume Title
Title
Novel Methods of Monitoring the Synthesis of N-L-Leucyldoxorubicin: MEKC-LIF and HPLC-LIF-MS
Alternative title
Authors
Published Date
2010-04-21
Publisher
Type
Presentation
Abstract
Multiple-step chemical syntheses need to be monitored and characterized between steps. Normally, Thin-Layer Chromatography (TLC), High-Performance Liquid Chromatography (HPLC) and/or Mass Spectrometry (MS) are sufficient. However, these normal methods sometimes fail for a number of reasons. Because of this, more sensitive and selective methods of monitoring reactions were developed. Capillary Electrophoresis coupled with Laser-Induced Fluorescence detection (CE-LIF) is an extremely sensitive technique that can be effectively used to determine the presence of and separate fluorescent compounds. HPLC-LIF-MS is a technique used to first separate compounds on an HPLC column, then to detect and measure only fluorescent peaks with Mass Spectrometry. Because Doxorubicin and its derivatives are fluorescent, these methods can be used efficiently and effectively.
Keywords
Description
Additional contributors: Chad Satori; Yaohua Wang; Joseph Katzenmeyer; George Barany; Edgar Arriaga (faculty mentor).
Related to
Replaces
License
Series/Report Number
Funding information
Isbn identifier
Doi identifier
Previously Published Citation
Other identifiers
Suggested citation
Meyer, Brandon. (2010). Novel Methods of Monitoring the Synthesis of N-L-Leucyldoxorubicin: MEKC-LIF and HPLC-LIF-MS. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/61598.
Content distributed via the University Digital Conservancy may be subject to additional license and use restrictions applied by the depositor. By using these files, users agree to the Terms of Use. Materials in the UDC may contain content that is disturbing and/or harmful. For more information, please see our statement on harmful content in digital repositories.